It’s been another busy and exciting year here at BioInformatics, now part of Science and Medicine Group. Together with our sister brands, Instrument Business Outlook, IMV Medical Information, Kalorama Information and Strategic Directions International, we’ve been helping clients achieve success through our quantitative and qualitative custom research services, our market research reports and industry data […]
In this article we discuss some of the product categories covered by the SDi Global Assessment Report 2018: The Laboratory Analytical & Life Science Instrumentation Industry. The SDi Global Report is comprised of ten major sections, each devoted to a major class of instrumentation. Here’s what manufacturers can expect in 2018. Chromatography: Mobile and High […]
Last week, we highlighted key advantages of Portable Molecular Spectroscopy. While portable spectrometers make it possible to analyze unknown materials, analyzing unknown and unexplored information from DNA is just as crucial. Recently, scientists have been able to gather much information from our exons, the parts of DNA that are considered coding regions for proteins. However, […]
Yesterday we announced that the 2018 SDi Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry will be released in conjunction with PITTCON, which will take place from February 26 – March 1, 2018. It made me think about what an interesting year it’s been for the life science and analytical instrument market […]
The 2017 Market for NGS Informatics: Probing the Commercial Landscape is designed to help companies navigate the crowded market for products and services that support Next Generation Sequencing (NGS) data analysis and storage. Scientists face many challenges when choosing a solution: it is often difficult to determine the significance of results, the storage space needed […]
Laboratories around the world are generating raw sequencing data at an unprecedented rate. Today it is possible to generate hundreds of millions of relatively short sequences in a single run in a short period of time with low per base cost. These technological developments have enabled widespread adoption of sequencing. At the same time, the […]
BioInformatics has become the preeminent leader in the market for commercial and VOC data, analysis and industry-wide opinions about the hottest topic in the life sciences: CRISPR/Cas9 technology. (See our complimentary report The CRISPR Toolbox.) In the 2016 Life Science Global Lab Funding & Budget Outlook, we polled members of The Science Advisory Board and asked: “What do […]
We’re officially into the second half of 2015 and, inevitably, smack dab in the “Summer Doldrums.” While a good portion of the world takes their holiday at this time of year, BioInformatics is in the midst of preparing its most comprehensive report, The 2016 Global Life Science Funding and Budget Outlook. Comprised of both secondary […]
NGS service providers conservatively prepare five times the number of NGS libraries per week as those prepared by individual labs (those labs that don’t routinely provide NGS as a service).
Next generation sequencing (NGS) is a disruptive technology with an ever-increasing number of users and applications. As such, it is the fastest growing and most attractive segment of all the different technologies that comprise the genomics universe.
March 30, 2021 11:47 am
October 27, 2020 2:01 pm
June 12, 2020 1:50 pm
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.